Lindus Health and Quotient Sciences have announced a strategic partnership to enable enhanced patient recruitment and ...

Title21 Health Solutions, a portfolio company specialising in supporting life science regulatory needs, has joined the Blood ...

Finnish biotechnology company NADMED has announced the launch of the NADMED Award 2026 in the hope of generating new ...

Xmoor Pharma has established a strategic collaboration with the Translational Research Office (TRO) and University College ...

Miranda Dini has announced the launch of GOLD Strategy & Communications, a global healthcare consultancy designed to provide ...

Genfit has announced encouraging preliminary results from its phase 1b clinical trial evaluating investigational drug GNS561 in combination with a MEK inhibitor (MEKi) in patients with KRAS mutated ...

GRI Bio has announced positive topline results from its phase 2a clinical trial evaluating GRI-0621 in idiopathic pulmonary ...

Johnson & Johnson has reported groundbreaking results from the phase 3 MajesTEC-3 study, highlighting the potential of ...

Modus Therapeutics Holding AB has announced that the first patient has been dosed in part 2 of its ongoing phase 2a clinical study evaluating sevuparin for the treatment of chronic kidney disease (CKD ...

Steven Pipe, Professor of Pediatrics and Pathology at the University of Michigan, explained: “The five-year HOPE-B results ...

Enterprise Therapeutics has announced the publication of results from its phase 1 study of ETD001, a long-acting inhaled ...